TGFβ-IN-3
TGFβ-IN-3 (Compound 8) is a long-acting prodrug that acts as a TGFβR1 inhibitor with tumor-targeting activation. It enables selective drug release within tumors, offering a 2.2-fold increase in the tumor-to-blood ratio. TGFβ-IN-3 is applicable for colon cancer research.
Product Specifications
CAS Number
2857845-34-0
Smiles
C (COCNC (OCC1=CC=C (NC ([C@@H] (NC (CNC ([C@@H] (NC ([C@@H] (NC (COCCOCCNC (COCCOCCNC (CC[C@H] (NC (CCCCCCCCCCCCCCCCC (O) =O) =O) C (O) =O) =O) =O) =O) CC (C) C) =O) CO) =O) =O) CCCCN) =O) C=C1) =O) N2C (=C (N=C2) C3=CC (Cl) =C (F) C=C3) C4=NN5C (C=C4) =NC=C5C#N
Molecular Formula
C79H114ClFN16O20
Molecular Weight
1662.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15155203 1 Vial
Lentiviral mouse Bace1 shRNA (UAS) - Lentiviral mouse Bace1 shRNA (UAS) plasmid
Sign In for Pricing
View Details 
037317-ML550 100 µL
KCNIP2, NT (KCNIP2, KCHIP2, Kv channel-interacting protein 2, A-type potassium channel modulatory protein 2, Cardiac voltage-gated potassium channel modulatory subunit, Potassium channel-interacting protein 2) (MaxLight 550) discontinued
Sign In for Pricing
View Details 